ANJI PHARMA

Serial Number 90094836
606

Registration Progress

Application Filed
Aug 5, 2020
Under Examination
Aug 31, 2021
Approved for Publication
Jul 6, 2021
Published for Opposition
Jul 6, 2021
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ANJI PHARMA
Previous Owner: Anji Pharmaceuticals Inc.
Classes: 005

Trademark Image

ANJI PHARMA

Basic Information

Serial Number
90094836
Filing Date
August 5, 2020
Published for Opposition
July 6, 2021
Abandonment Date
April 1, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 1, 2024
Classes
005

Rights Holder

Anji Pharmaceuticals Inc.

03
Address
245 Main Street
Cambridge, MA 02142

Ownership History

Anji Pharmaceuticals Inc.

Original Applicant
03
Cambridge, MA

Anji Pharmaceuticals Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Nicole Kinsley, Esq.

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

36 events
Date Code Type Description Documents
Apr 1, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 1, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 3, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 3, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 3, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 30, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 9, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 7, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 7, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 7, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 17, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 15, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 15, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 15, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 11, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 31, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 6, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 6, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 16, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 28, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 26, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 26, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 26, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 1, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 1, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 1, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 30, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 3, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 8, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for pharmaceutical preparations; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"